VERTEX PHARMACEUTICALS INC / MA

SEC 4 · Filed

0000875320-26-000129Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 27, 2026

Sale by Kewalramani Reshma

Security
Common Stock
Code
S
Shares
1,725
Price per share
496.95
Structured facts
{
  "code": "S",
  "date": "2026-02-27",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction made pursuant to Dr. Kewalramani\u0027s company approved trading plan under Rule 10b5-1, which was entered into on 11/17/2025.",
    "F15": "Open market sales reported on this line occurred at a weighted average price of $496.95 (range $496.79 to $497.17).",
    "F2": "Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."
  },
  "owners": [
    {
      "cik": "0001735944",
      "name": "Kewalramani Reshma",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO \u0026 President"
    }
  ],
  "ownership": "D",
  "post_shares": "98278",
  "price": "496.95",
  "row": 13,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "1725",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Feb 27, 2026

Sale by Kewalramani Reshma

Security
Common Stock
Code
S
Shares
5,995
Price per share
496.16
Structured facts
{
  "code": "S",
  "date": "2026-02-27",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction made pursuant to Dr. Kewalramani\u0027s company approved trading plan under Rule 10b5-1, which was entered into on 11/17/2025.",
    "F14": "Open market sales reported on this line occurred at a weighted average price of $496.16 (range $495.79 to $496.74).",
    "F2": "Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."
  },
  "owners": [
    {
      "cik": "0001735944",
      "name": "Kewalramani Reshma",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO \u0026 President"
    }
  ],
  "ownership": "D",
  "post_shares": "100003",
  "price": "496.16",
  "row": 12,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "5995",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Feb 27, 2026

Sale by Kewalramani Reshma

Security
Common Stock
Code
S
Shares
15,580
Price per share
495.38
Structured facts
{
  "code": "S",
  "date": "2026-02-27",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction made pursuant to Dr. Kewalramani\u0027s company approved trading plan under Rule 10b5-1, which was entered into on 11/17/2025.",
    "F13": "Open market sales reported on this line occurred at a weighted average price of $495.38 (range $494.79 to $495.78).",
    "F2": "Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."
  },
  "owners": [
    {
      "cik": "0001735944",
      "name": "Kewalramani Reshma",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO \u0026 President"
    }
  ],
  "ownership": "D",
  "post_shares": "105998",
  "price": "495.38",
  "row": 11,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "15580",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Feb 27, 2026

Sale by Kewalramani Reshma

Security
Common Stock
Code
S
Shares
3,498
Price per share
494.33
Structured facts
{
  "code": "S",
  "date": "2026-02-27",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction made pursuant to Dr. Kewalramani\u0027s company approved trading plan under Rule 10b5-1, which was entered into on 11/17/2025.",
    "F12": "Open market sales reported on this line occurred at a weighted average price of $494.33 (range $493.78 to $494.75).",
    "F2": "Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."
  },
  "owners": [
    {
      "cik": "0001735944",
      "name": "Kewalramani Reshma",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO \u0026 President"
    }
  ],
  "ownership": "D",
  "post_shares": "121578",
  "price": "494.33",
  "row": 10,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "3498",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Feb 27, 2026

Sale by Kewalramani Reshma

Security
Common Stock
Code
S
Shares
2,520
Price per share
493.29
Structured facts
{
  "code": "S",
  "date": "2026-02-27",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction made pursuant to Dr. Kewalramani\u0027s company approved trading plan under Rule 10b5-1, which was entered into on 11/17/2025.",
    "F11": "Open market sales reported on this line occurred at a weighted average price of $493.29 (range $492.78 to $493.77).",
    "F2": "Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."
  },
  "owners": [
    {
      "cik": "0001735944",
      "name": "Kewalramani Reshma",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO \u0026 President"
    }
  ],
  "ownership": "D",
  "post_shares": "125076",
  "price": "493.29",
  "row": 9,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "2520",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Feb 27, 2026

Sale by Kewalramani Reshma

Security
Common Stock
Code
S
Shares
949
Price per share
491.30
Structured facts
{
  "code": "S",
  "date": "2026-02-27",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction made pursuant to Dr. Kewalramani\u0027s company approved trading plan under Rule 10b5-1, which was entered into on 11/17/2025.",
    "F10": "Open market sales reported on this line occurred at a weighted average price of $491.30 (range $491.13 to $491.85).",
    "F2": "Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."
  },
  "owners": [
    {
      "cik": "0001735944",
      "name": "Kewalramani Reshma",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO \u0026 President"
    }
  ],
  "ownership": "D",
  "post_shares": "127596",
  "price": "491.30",
  "row": 8,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "949",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Feb 27, 2026

Sale by Kewalramani Reshma

Security
Common Stock
Code
S
Shares
2,725
Price per share
490.54
Structured facts
{
  "code": "S",
  "date": "2026-02-27",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction made pursuant to Dr. Kewalramani\u0027s company approved trading plan under Rule 10b5-1, which was entered into on 11/17/2025.",
    "F2": "Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.",
    "F9": "Open market sales reported on this line occurred at a weighted average price of $490.54 (range $490.10 to $491.01)."
  },
  "owners": [
    {
      "cik": "0001735944",
      "name": "Kewalramani Reshma",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO \u0026 President"
    }
  ],
  "ownership": "D",
  "post_shares": "128545",
  "price": "490.54",
  "row": 7,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "2725",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Feb 27, 2026

Sale by Kewalramani Reshma

Security
Common Stock
Code
S
Shares
460
Price per share
489.32
Structured facts
{
  "code": "S",
  "date": "2026-02-27",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction made pursuant to Dr. Kewalramani\u0027s company approved trading plan under Rule 10b5-1, which was entered into on 11/17/2025.",
    "F2": "Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.",
    "F8": "Open market sales reported on this line occurred at a weighted average price of $489.32 (range $489.01 to $489.79)."
  },
  "owners": [
    {
      "cik": "0001735944",
      "name": "Kewalramani Reshma",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO \u0026 President"
    }
  ],
  "ownership": "D",
  "post_shares": "131270",
  "price": "489.32",
  "row": 6,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "460",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Feb 27, 2026

Sale by Kewalramani Reshma

Security
Common Stock
Code
S
Shares
3,278
Price per share
488.27
Structured facts
{
  "code": "S",
  "date": "2026-02-27",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction made pursuant to Dr. Kewalramani\u0027s company approved trading plan under Rule 10b5-1, which was entered into on 11/17/2025.",
    "F2": "Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.",
    "F7": "Open market sales reported on this line occurred at a weighted average price of $488.27 (range $487.82 to $488.56)."
  },
  "owners": [
    {
      "cik": "0001735944",
      "name": "Kewalramani Reshma",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO \u0026 President"
    }
  ],
  "ownership": "D",
  "post_shares": "131730",
  "price": "488.27",
  "row": 5,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "3278",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Feb 27, 2026

Sale by Kewalramani Reshma

Security
Common Stock
Code
S
Shares
2,510
Price per share
487.13
Structured facts
{
  "code": "S",
  "date": "2026-02-27",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction made pursuant to Dr. Kewalramani\u0027s company approved trading plan under Rule 10b5-1, which was entered into on 11/17/2025.",
    "F2": "Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.",
    "F6": "Open market sales reported on this line occurred at a weighted average price of $487.13 (range $486.64 to $487.55)."
  },
  "owners": [
    {
      "cik": "0001735944",
      "name": "Kewalramani Reshma",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO \u0026 President"
    }
  ],
  "ownership": "D",
  "post_shares": "135008",
  "price": "487.13",
  "row": 4,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "2510",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Feb 27, 2026

Sale by Kewalramani Reshma

Security
Common Stock
Code
S
Shares
240
Price per share
482.84
Structured facts
{
  "code": "S",
  "date": "2026-02-27",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction made pursuant to Dr. Kewalramani\u0027s company approved trading plan under Rule 10b5-1, which was entered into on 11/17/2025.",
    "F2": "Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.",
    "F5": "Open market sales reported on this line occurred at a weighted average price of $482.84 (range $482.84 to $482.85)."
  },
  "owners": [
    {
      "cik": "0001735944",
      "name": "Kewalramani Reshma",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO \u0026 President"
    }
  ],
  "ownership": "D",
  "post_shares": "137518",
  "price": "482.84",
  "row": 3,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "240",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Feb 27, 2026

Sale by Kewalramani Reshma

Security
Common Stock
Code
S
Shares
120
Price per share
481.50
Structured facts
{
  "code": "S",
  "date": "2026-02-27",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction made pursuant to Dr. Kewalramani\u0027s company approved trading plan under Rule 10b5-1, which was entered into on 11/17/2025.",
    "F2": "Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.",
    "F4": "Open market sales reported on this line occurred at a weighted average price of $481.50 (range $481.50 to $481.51)."
  },
  "owners": [
    {
      "cik": "0001735944",
      "name": "Kewalramani Reshma",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO \u0026 President"
    }
  ],
  "ownership": "D",
  "post_shares": "137758",
  "price": "481.50",
  "row": 2,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "120",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Feb 27, 2026

Sale by Kewalramani Reshma

Security
Common Stock
Code
S
Shares
400
Price per share
479.75
Structured facts
{
  "code": "S",
  "date": "2026-02-27",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Transaction made pursuant to Dr. Kewalramani\u0027s company approved trading plan under Rule 10b5-1, which was entered into on 11/17/2025.",
    "F2": "Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.",
    "F3": "Open market sales reported on this line occurred at a weighted average price of $479.75 (range $479.75 to $479.76)."
  },
  "owners": [
    {
      "cik": "0001735944",
      "name": "Kewalramani Reshma",
      "roles": [
        "director",
        "officer"
      ],
      "title": "CEO \u0026 President"
    }
  ],
  "ownership": "D",
  "post_shares": "137878",
  "price": "479.75",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "400",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}